Ophthal

Your Article Summary

See Latest Articles

Treatment Modalities for Graves' Ophthalmopathy - Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 06/15/09

Stiebel-Kalish H et al. - Current evidence demonstrates the efficacy of intravenous corticosteroids in decreasing CAS in patients with moderate-to-severe GO. Intravenous pulse corticosteroids therapy has a small but statistically significant advantage oral therapy, and causes significantly less adverse events. Somatostatin analogs have marginal clinical efficacy. The efficacy of orbital radiotherapy as single therapy remains unclear, while the combination of radiotherapy with corticosteroids has better efficacy than either radiotherapy or oral costicosteroids alone.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Patients' preferences for positioning during phaco-emulsification under topical-intracameral anaesthesia
Clinical and Experimental Ophthalmology, 10/13/09

Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09

Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09

See All of Clinical Pharmacology

Today in Neuro-Ophthalmology...keeping you current

Receive free subspecialty "5-minute updates" via email

Headache and the eye
Current Opinion in Ophthalmology, 10/19/09

Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients
Eye, 10/20/09

Neuromyelitis optica: current concepts and prospects for future management
Current Opinion in Ophthalmology, 10/16/09

See All of Neuro-Ophthalmology